Latest filing published 09 Apr 2015 for Tempest Therapeutics, Inc., €4,645.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -68.9%Entry US$93,249.00 · Close at T+365 US$28,986.75
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Theresa McNeely: trading record in brief
This profile gathers the share dealings of Theresa McNeely in Tempest Therapeutics, Inc. In total, 2 filings cover trades dated from 8 April 2015 to 9 April 2015.
Purchases make up the whole of the open-market record (2 purchases, €11k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The newest entry dates from 9 April 2015: an open-market purchase of €4,645, in Tempest Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Theresa McNeely
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 174 shares@ US$28.79Common StockSEC:0001179110-15-006171:0Canonical exit: 7 Jul 2015 (T+90)
- 226 shares@ US$29.68Common StockSEC:0001179110-15-006171:1Canonical exit: 8 Jul 2015 (T+90)
2 of 2 declarations
